Everyone has GenAI ideas. Few organizations have a clear, aligned strategy for where to focus, what to prioritize, and how to turn those ideas into measurable outcomes. Without that clarity, teams pursue disconnected initiatives, compete for resources, and struggle to show real value.
To successfully scale GenAI, leaders need a shared North Star, a prioritized portfolio, and an execution-ready plan—so the organization can move from experimentation to coordinated, high-impact delivery.
Why GenAI Strategy Breaks at Scale
- How well do we really understand our customer’s core “Jobs to be Done” and ways that AI could add significant value?
- Where should GenAI focus to drive measurable business outcomes not just experiments?
- Do we have a clear definition of what “winning with GenAI” looks like?
Our Solution — Define and Activate Your GenAI Strategy
Your True North Strategy Accelerator At-A-Glance
Explore (Week 1)
Explore (Week 1)
- 2-Hour Leadership Alignment & Action Planning Session
- Quick Wins Playbook
- Actionable Next Steps
- High-Level Comms PlanAccelerate
- On-Demand Coaching
Align and Mobilize (Week 2)
Align and Mobilize (Week 2)
- 2-Hour Leadership Alignment & Action Planning Session
- Quick Wins Playbook
- Actionable Next Steps
- High-Level Comms PlanAccelerate
- On-Demand Coaching
Outcomes you can expect
Fewer “bad answers” in production because GenAI is constrained to curated, approved sources with required metadata.
Fewer “bad answers” in production because GenAI is constrained to curated, approved sources with required metadata.
Fewer “bad answers” in production because GenAI is constrained to curated, approved sources with required metadata.
Fewer “bad answers” in production because GenAI is constrained to curated, approved sources with required metadata.
Fewer “bad answers” in production because GenAI is constrained to curated, approved sources with required metadata.
Frequently Asked Questions
- What changes when GenAI demand shifts from pilots to production workflows?
In practice, that’s when informal coordination breaks. Intake becomes political, standards drift, and no one owns the release thresholds. A formal Center of Enablement with clear decision rights, intake criteria, and review routines prevents fragmented scale and unmanaged exposure. - What happens if we don’t formalize a CoE now?
You’ll see duplicated use cases, inconsistent guardrails, and rising exception requests with no central audit trail. Without named owners and enforceable standards, risk accumulates quietly while costs rise visibly. - Where do efforts fail when scaling GenAI without structure?
They fail at prioritization and proof. Teams build what’s loudest, not what’s highest value, and leaders lack measurable controls or evidence they can produce on demand.
- What does “good” look like in 90 days?
You’ll leave with a defined CoE charter, intake workflow, reusable standards pack, and a 90-day backlog with named owners. Leaders will review measurable progress weekly using agreed success indicators. - If we’re already experimenting with GenAI, what’s missing?
Usually decision rights, release discipline, and reuse. We embed a clear approval model, pattern library, and review cadence so experimentation turns into structured throughput. - What tangible artifacts will we have?
A formal charter, intake criteria, prioritization backlog, reusable prompt and testing standards, review routines, and an audit-ready trail for high-risk releases.
- How do we avoid boiling the ocean?
We focus on the few controls that unlock scale: intake discipline, decision rights, reusable standards, and measurable proof. The CoE model works with your existing toolchain and governance realities. - What if we operate in a federated model across business units?
We clarify shared standards and local flexibility. The CoE defines non-negotiables—intake gates, approval thresholds, review routines—while allowing domain-specific adaptation. - Will this disrupt current teams and delivery timelines?
No. We align to existing workflows and embed standards into release gates, not parallel processes. The goal is fewer escalations and less rework—not added friction.
- What leading indicators show progress?
We make it measurable by tracking intake flow, backlog throughput, reuse rates, and exception trends. Leaders review visible dashboards weekly. - How do we demonstrate risk reduction?
We prove progress with fewer unmanaged releases, clearer approval records, and a defensible audit trail tied to release decisions and exceptions. - Can we show real business impact?
Yes. We link prioritized use cases to productivity gains, cost-to-serve improvements, and time-to-value reduction—tracked through the CoE backlog and review cadence.
- What keeps the CoE from becoming overhead?
We embed ownership by assigning named leaders, decision rights, and a governance cadence tied to measurable outcomes. Authority and proof prevent drift. - How do we sustain standards over time?
We keep it sustainable by integrating standards into intake and release gates, reinforcing reuse, and reviewing exception patterns quarterly. - How do we maintain trust as adoption expands?
We standardize review routines, maintain an audit-ready trail for high-risk releases, and provide leaders with proof they can defend externally if needed.